Risk of HIV transmission from patients on antiretroviral therapy: A position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy

Jan Albert From the Department of Microbiology, Tumour and Cell Biology, Karolinska Institutet, Stockholm;Department of Clinical Microbiology, Karolinska University Hospital, Stockholm;The Swedish Reference Group for Antiviral Therapy, SolnaCorrespondence[email protected]

Torsten BerglundThe Public Health Agency of Sweden, Solna

Magnus GisslénThe Swedish Reference Group for Antiviral Therapy, Solna;Department of Infectious Diseases, University of Gothenburg, Gothenburg

Peter GröönDepartment of Communicable Diseases Control and Prevention, Stockholm County Council, Stockholm

Anders SönnerborgDepartment of Clinical Microbiology, Karolinska University Hospital, Stockholm;The Swedish Reference Group for Antiviral Therapy, Solna;Department of Laboratory Medicine, Division of Clinical Microbiology, Karolinska Institutet, Stockholm;Department of Infectious Diseases, Karolinska University Hospital, Stockholm

Anders TegnellThe Public Health Agency of Sweden, Solna

Anders AlexanderssonNational Board of Health and Welfare, Stockholm

Ingela BerggrenDepartment of Communicable Diseases Control and Prevention, Stockholm County Council, Stockholm

Anders BlaxhultVenhälsan/Infektion, Södersjukhuset, Stockholm

Maria BryttingThe Swedish Reference Group for Antiviral Therapy, Solna;The Public Health Agency of Sweden, Solna

Christina CarlanderClinic of Infectious Diseases, County Hospital of Västmanland, Västerås

Johan CarlsonThe Public Health Agency of Sweden, Solna

Leo FlamholcThe Swedish Reference Group for Antiviral Therapy, Solna;Department of Infectious Diseases, University of Lund, Skåne University Hospital, Malmö

Per FollinDepartment of Communicable Disease Control and Prevention, Region Västra Götaland, Gothenburg

Axana HaggarNational Board of Health and Welfare, Stockholm

Frida HansdotterThe Public Health Agency of Sweden, Solna

Filip JosephsonThe Swedish Reference Group for Antiviral Therapy, Solna;Swedish Medical Products Agency, Uppsala

Olle KarlströmThe Swedish Reference Group for Antiviral Therapy, Solna;Department of Infectious Diseases, Karolinska University Hospital, Stockholm;Swedish Medical Products Agency, Uppsala

Fredrik LiljerosDepartment of Sociology, Stockholm University, Stockholm

Lars NavérThe Swedish Reference Group for Antiviral Therapy, Solna;Department of Paediatrics, Karolinska University Hospital, Stockholm;Department of Clinical Science, Intervention and Technology, Karolinska Institute, Stockholm

Karin PetterssonThe Swedish Reference Group for Antiviral Therapy, Solna;Department of Obstetrics, Karolinska University Hospital, Huddinge, Stockholm

Veronica Svedhem JohanssonDepartment of Infectious Diseases, Karolinska University Hospital, Stockholm;Unit of Infectious Diseases, Department of Medicine Huddinge, Karolinska Institutet, Stockholm

Bo SvennerholmThe Swedish Reference Group for Antiviral Therapy, Solna;Department of Clinical Virology, Sahlgrenska Academy, University of Gothenburg, Gothenburg

Petra TunbäckThe Swedish Reference Group for Antiviral Therapy, Solna;Department of Dermatovenereology, University of Gothenburg, Gothenburg, Sweden

Katarina WidgrenThe Public Health Agency of Sweden, Solna

show all

Risk of HIV transmission from patients on antiretroviral therapy: A position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Risk of HIV transmission from patients on antiretroviral therapy: A position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date